Efficacy outcomes
SECONDARY
The primary efficacy endpoint was achieved by most of the iWONde participants (14/21, 67%) who enrolled in the present study and underwent the VARTD approach (Table Primary and secondary efficacy endpointsVARTD, video-assisted retroperitoneal and/or transperitoneal debridement; AP, anteroposterior